0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Medical News & Perspectives |

Easy-to-Use Overdose Antidote Earns Fast-Track Approval

Bridget M. Kuehn, MSJ
JAMA. 2014;311(16):1600. doi:10.1001/jama.2014.4483.
Text Size: A A A
Published online

Extract

An easy-to-use opioid overdose antidote for outpatients has gained approval from the US Food and Drug Administration (FDA) in just 15 weeks. Physicians may prescribe the drug to someone taking opioids or to other members of the household who may be at risk, such as child who might ingest a parent’s medication, according to FDA spokeswoman Sandy Walsh.

The product, called Evzio, is an autoinjectable device containing a single dose of naloxone.

Naloxone has long been a staple in emergency departments, where it is used to reverse the effects of an overdose of an illicit or prescription opioid. It is also used to reverse the effects of anesthesia. But local and national organizations have worked to make the drug more widely available in the community to combat an ongoing epidemic of opioid overdoses. According to the FDA, there were 16 000 deaths from overdose of prescription opioids in 2010 and 3000 heroin overdoses.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Dexmedetomidine in the Treatment of Serotonin Syndrome. Ann Pharmacother Published online Aug 28, 2014.;
Treatment for calcium channel blocker poisoning: A systematic review. Clin Toxicol (Phila) Published online Oct 6, 2014.;
Jobs
brightcove.createExperiences();